Given that obesity is a major modifiable risk factor for OSAS, and that the pathogenesis of OSAS involves metabolic dysregulation, systemic inflammation, and abnormal adipose tissue distribution, tirzepatide may offer multidimensional therapeutic benefits in this context (26)
But an empty stomach can actually make nausea worse
With that in mind, we curated a GLP-1 starter pack of smart essentials to help you stay supported and on track throughout your weight-loss journey
Key Takeaways Retatrutide is a novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors to effectively regulate hunger and energy expenditure, marking a significant advancement in obesity treatment
NEJM 2023 still anchors most new protocol frameworks
I feel like a lot of people have this stigma on GLP-1s and say things like, Oh, lazy people do it, or If youre working hard enough, you dont need that, she shares